Healthcare

Analysis of the Clinical Next-generation Sequencing Sector, Global, 2024-2030

Continued Investment in AI is Driving Transformational Growth by Accelerating Information Solutions Development

INDUSTRY
Healthcare

RELEASE DATE
08-Nov-2024
REGION
Global
DELIVERABLE TYPE
Market Research

RESEARCH CODE
KAE6-01-00-00-00
SKU
HC_2024_1121
Yes
SHARE

Analysis of the Clinical Next-generation Sequencing Sector, Global, 2024-2030
Published on: 08-Nov-2024 | SKU: HC_2024_1121

Need more details?

$4,950.00

$4,207.50 save 15 %

DownloadLink
Need more details?

This Frost & Sullivan analysis examines the clinical next-generation sequencing (NGS) industry, covering the different type of products, workflows, and applications for clinical purposes. The global market is projected to grow steadily from 2024 to 2030, achieving significant revenue milestones, driven largely by services and informatics segments. The NGS market encompasses end-to-end workflows, including library preparation, sequencing, and data analysis and interpretation, specifically designed for clinical applications across key end-user segments: pharmaceutical and biotechnology, and diagnostics. Within these sectors, NGS technologies are primarily employed to diagnose and monitor diseases, as well as for companion diagnostics, clinical trials, and patient stratification.

This analysis assesses the factors driving and restraining the growth of the use of NGS technology in clinical settings and offers case studies from North America, Europe, Asia-Pacific (APAC), Latin America, and the Middle East, Africa, and South Asia (MEASA). It also identifies the core growth opportunities that the industry presents by evaluating industry segments, the regulatory environment, and emerging business models, as well as market revenue and forecasts.

Scope of Analysis

Segmentation

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Clinical Next-generation Sequencing Industry

Competitive Environment

Key Competitors

Growth Metrics

Growth Drivers

Growth Restraints

Forecast Considerations

Revenue Forecast

Revenue Forecast by Product

Revenue Forecast by Workflow

Revenue Forecast by Application

Revenue Forecast by Region

Revenue Forecast Analysis

Revenue Forecast Analysis (continued)

Pricing Trends and Forecast Analysis

Revenue Share

Revenue Share Analysis

Competitive Players

Competitive Players (continued)

Company Informatics Solutions for Applications

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Forecast Analysis

Forecast Analysis (continued)

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Forecast Analysis

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Forecast Analysis

Forecast Analysis (continued)

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Forecast Analysis

Forecast Analysis (continued)

Growth Opportunity 1: Integration of Multi-omics Data for Personalized Medicine

Growth Opportunity 1: Integration of Multi-omics Data for Personalized Medicine (continued)

Growth Opportunity 2: Minimal Residual Disease Detection and Treatment in Cancer

Growth Opportunity 2: Minimal Residual Disease Detection and Treatment in Cancer (continued)

Growth Opportunity 3: Expansion of Single-cell and Spatial Omics in Clinical Research

Growth Opportunity 3: Expansion of Single-cell and Spatial Omics in Clinical Research (continued)

Growth Opportunity 4: Genomics Initiatives and Bioinformatics Development in APAC and MEASA

Growth Opportunity 4: Genomics Initiatives and Bioinformatics Development in APAC and MEASA (continued)

Benefits and Impacts of Growth Opportunities

Next Steps

List of Exhibits

List of Exhibits (continued)

Legal Disclaimer

List of Figures
  • Clinical NGS: Growth Metrics, Global, 2024
  • Clinical NGS: Growth Drivers, Global, 2025-2030
  • Clinical NGS: Growth Restraints, Global, 2025-2030
  • Clinical NGS: Revenue Forecast, Global, 2024-2030
  • Clinical NGS: Revenue Forecast by Product, Global, 2024-2030
  • Clinical NGS: Revenue Forecast by Workflow, Global, 2024-2030
  • Clinical NGS: Revenue Forecast by Application, Global, 2024-2030
  • Clinical NGS: Revenue Forecast by Region, Global, 2024-2030
  • Clinical NGS: Revenue Share of Top 4 Participants, Global, 2024
  • Instruments: Growth Metrics, Global, 2024
  • Instruments: Revenue Forecast, Global, 2024-2030
  • Instruments: Revenue Forecast by Region, Global, 2024-2030
  • Workflow Solutions: Growth Metrics, Global, 2024
  • Workflow Solutions: Revenue Forecast, Global, 2024-2030
  • Workflow Solutions: Revenue Forecast by Region, Global, 2024-2030
  • Services: Growth Metrics, Global, 2024
  • Services: Revenue Forecast, Global, 2024-2030
  • Services: Revenue Forecast by Region, Global, 2024-2030
  • Informatics: Growth Metrics, Global, 2024
  • Informatics: Revenue Forecast, Global, 2024-2030
  • Informatics: Revenue Forecast by Region, Global, 2024-2030

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

17 Nov 2026   |   Global   |   Frost Radar

Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026

Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...

16 Nov 2026   |   North America   |   Frost Radar

Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026

This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...

03 Nov 2026   |   North America   |   Market Research

Enterprise Imaging Market, United States, 2025–2030

Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...

02 Nov 2026   |   Global   |   Market Research

Continuous Glucose Monitoring Market, Global, 2026

The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...

28 Oct 2026   |   Global   |   Frost Radar

Frost Radar™: Health Monitoring Wearable Solutions, 2026

The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.